+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Stromal Cell Derived Factor"

Stromal Cell Derived Factor 1 - Pipeline Review, H2 2019 - Product Thumbnail Image

Stromal Cell Derived Factor 1 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 66 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Stromal Cell Derived Factor (SDF) is a type of oncology drug that is used to treat cancer. It is a type of cytokine, which is a protein that helps regulate the immune system. SDF works by stimulating the production of immune cells, which can help fight cancer cells. It is also used to reduce the side effects of chemotherapy and radiation therapy. SDF is used in combination with other treatments, such as chemotherapy and radiation therapy, to improve the effectiveness of the treatment. SDF is used to treat a variety of cancers, including breast, lung, and colorectal cancer. It is also used to treat other conditions, such as multiple myeloma and lymphoma. SDF is available in both injectable and oral forms. The SDF market is growing rapidly, as more and more oncology drugs are being developed to treat cancer. Companies such as Novartis, Merck, and Pfizer are leading the way in developing SDF-based treatments. Other companies, such as Amgen, Celgene, and Gilead Sciences, are also involved in the development of SDF-based treatments. Show Less Read more